vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and loanDepot, Inc. (LDI). Click either name above to swap in a different company.
loanDepot, Inc. is the larger business by last-quarter revenue ($310.3M vs $208.9M, roughly 1.5× iRhythm Holdings, Inc.). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs -7.2%, a 9.9% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 20.5%). iRhythm Holdings, Inc. produced more free cash flow last quarter ($14.5M vs $-648.0M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 18.0%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
LoanDepot, sometimes stylized as loanDepot, is an Irvine, California-based nonbank holding company which sells mortgage and non-mortgage lending products.
IRTC vs LDI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $310.3M |
| Net Profit | $5.6M | $-22.5M |
| Gross Margin | 70.9% | — |
| Operating Margin | 1.1% | -10.3% |
| Net Margin | 2.7% | -7.2% |
| Revenue YoY | 27.1% | 20.5% |
| Net Profit YoY | 518.5% | 32.4% |
| EPS (diluted) | $0.18 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $208.9M | $310.3M | ||
| Q3 25 | $192.9M | $323.3M | ||
| Q2 25 | $186.7M | $282.5M | ||
| Q1 25 | $158.7M | $273.6M | ||
| Q4 24 | $164.3M | $257.5M | ||
| Q3 24 | $147.5M | $314.6M | ||
| Q2 24 | $148.0M | $265.4M | ||
| Q1 24 | $131.9M | $222.8M |
| Q4 25 | $5.6M | $-22.5M | ||
| Q3 25 | $-5.2M | $-4.9M | ||
| Q2 25 | $-14.2M | $-13.4M | ||
| Q1 25 | $-30.7M | $-21.9M | ||
| Q4 24 | $-1.3M | $-33.2M | ||
| Q3 24 | $-46.2M | $1.4M | ||
| Q2 24 | $-20.1M | $-32.2M | ||
| Q1 24 | $-45.7M | $-34.3M |
| Q4 25 | 70.9% | — | ||
| Q3 25 | 71.1% | — | ||
| Q2 25 | 71.2% | — | ||
| Q1 25 | 68.8% | — | ||
| Q4 24 | 70.0% | — | ||
| Q3 24 | 68.8% | — | ||
| Q2 24 | 69.9% | — | ||
| Q1 24 | 66.3% | — |
| Q4 25 | 1.1% | -10.3% | ||
| Q3 25 | -4.4% | -3.2% | ||
| Q2 25 | -10.0% | -11.4% | ||
| Q1 25 | -20.5% | -16.8% | ||
| Q4 24 | -2.5% | -32.7% | ||
| Q3 24 | -34.1% | 1.1% | ||
| Q2 24 | -15.5% | -29.1% | ||
| Q1 24 | -28.9% | -38.2% |
| Q4 25 | 2.7% | -7.2% | ||
| Q3 25 | -2.7% | -1.5% | ||
| Q2 25 | -7.6% | -4.7% | ||
| Q1 25 | -19.3% | -8.0% | ||
| Q4 24 | -0.8% | -12.9% | ||
| Q3 24 | -31.3% | 0.4% | ||
| Q2 24 | -13.6% | -12.1% | ||
| Q1 24 | -34.6% | -15.4% |
| Q4 25 | $0.18 | — | ||
| Q3 25 | $-0.16 | — | ||
| Q2 25 | $-0.44 | — | ||
| Q1 25 | $-0.97 | — | ||
| Q4 24 | $-0.03 | — | ||
| Q3 24 | $-1.48 | $0.01 | ||
| Q2 24 | $-0.65 | $-0.18 | ||
| Q1 24 | $-1.47 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | $337.2M |
| Total DebtLower is stronger | — | $2.1B |
| Stockholders' EquityBook value | $152.7M | $386.0M |
| Total Assets | $1.0B | $6.9B |
| Debt / EquityLower = less leverage | — | 5.44× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $583.8M | $337.2M | ||
| Q3 25 | $565.2M | $459.2M | ||
| Q2 25 | $545.5M | $408.6M | ||
| Q1 25 | $520.6M | $371.5M | ||
| Q4 24 | $535.6M | $421.6M | ||
| Q3 24 | $522.0M | $483.0M | ||
| Q2 24 | $561.5M | $533.2M | ||
| Q1 24 | $569.1M | $603.7M |
| Q4 25 | — | $2.1B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | — | $2.1B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | — | $2.3B |
| Q4 25 | $152.7M | $386.0M | ||
| Q3 25 | $121.9M | $433.3M | ||
| Q2 25 | $103.7M | $439.1M | ||
| Q1 25 | $86.7M | $469.3M | ||
| Q4 24 | $90.9M | $506.6M | ||
| Q3 24 | $71.8M | $592.0M | ||
| Q2 24 | $99.2M | $578.9M | ||
| Q1 24 | $90.3M | $637.3M |
| Q4 25 | $1.0B | $6.9B | ||
| Q3 25 | $995.2M | $6.2B | ||
| Q2 25 | $964.0M | $6.2B | ||
| Q1 25 | $926.1M | $6.4B | ||
| Q4 24 | $931.4M | $6.3B | ||
| Q3 24 | $909.7M | $6.4B | ||
| Q2 24 | $919.2M | $5.9B | ||
| Q1 24 | $909.8M | $6.2B |
| Q4 25 | — | 5.44× | ||
| Q3 25 | — | 4.83× | ||
| Q2 25 | — | 4.70× | ||
| Q1 25 | — | 4.30× | ||
| Q4 24 | — | 4.00× | ||
| Q3 24 | — | 3.31× | ||
| Q2 24 | — | 3.41× | ||
| Q1 24 | — | 3.63× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $-638.7M |
| Free Cash FlowOCF − Capex | $14.5M | $-648.0M |
| FCF MarginFCF / Revenue | 6.9% | -208.9% |
| Capex IntensityCapex / Revenue | 5.6% | 3.0% |
| Cash ConversionOCF / Net Profit | 4.70× | — |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | $-734.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.2M | $-638.7M | ||
| Q3 25 | $34.9M | $43.4M | ||
| Q2 25 | $27.7M | $67.6M | ||
| Q1 25 | $-7.9M | $-179.9M | ||
| Q4 24 | $19.2M | $47.7M | ||
| Q3 24 | $24.3M | $-349.2M | ||
| Q2 24 | $11.8M | $-278.3M | ||
| Q1 24 | $-52.0M | $-278.5M |
| Q4 25 | $14.5M | $-648.0M | ||
| Q3 25 | $20.1M | $38.7M | ||
| Q2 25 | $17.3M | $61.4M | ||
| Q1 25 | $-17.3M | $-186.7M | ||
| Q4 24 | $12.4M | $40.8M | ||
| Q3 24 | $15.5M | $-356.4M | ||
| Q2 24 | $3.4M | $-285.7M | ||
| Q1 24 | $-61.8M | $-283.3M |
| Q4 25 | 6.9% | -208.9% | ||
| Q3 25 | 10.4% | 12.0% | ||
| Q2 25 | 9.3% | 21.7% | ||
| Q1 25 | -10.9% | -68.2% | ||
| Q4 24 | 7.5% | 15.8% | ||
| Q3 24 | 10.5% | -113.3% | ||
| Q2 24 | 2.3% | -107.7% | ||
| Q1 24 | -46.8% | -127.2% |
| Q4 25 | 5.6% | 3.0% | ||
| Q3 25 | 7.7% | 1.5% | ||
| Q2 25 | 5.6% | 2.2% | ||
| Q1 25 | 5.9% | 2.5% | ||
| Q4 24 | 4.2% | 2.7% | ||
| Q3 24 | 6.0% | 2.3% | ||
| Q2 24 | 5.7% | 2.8% | ||
| Q1 24 | 7.4% | 2.1% |
| Q4 25 | 4.70× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -255.05× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
LDI
Segment breakdown not available.
